Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8400 (2.37%) ($13.2900 - $14.1600) on Mon. Jun. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.16% (three month average) | RSI | 70 | Latest Price | $13.8400(2.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 17.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.58% in a week (0% probabilities). VIXM(-32%) VXX(-27%) XLC(-9%) UUP(-9%) UNG(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.58% (StdDev 7.16%) | Hourly BBV | 0 () | Intraday Trend | 3.5% | | | |
|
5 Day Moving Average | $13.31(3.98%) | 10 Day Moving Average | $12.17(13.72%) | 20 Day Moving Average | $11.11(24.57%) | To recent high | -7.3% | To recent low | 83.8% | Market Cap | $1.028b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |